Detalhe da pesquisa
1.
Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition.
medRxiv
; 2024 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38370835
2.
Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.
Eur Urol
; 80(6): 746-757, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785256
3.
MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity.
Oncogene
; 39(34): 5663-5674, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32681068
4.
A case report of multiple primary prostate tumors with differential drug sensitivity.
Nat Commun
; 11(1): 837, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32054861
5.
Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer.
JCO Precis Oncol
; 32019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31528835